MediGene AG

MediGene AG
Stock Exchange Other OTC
EPS
$0.91
Market Cap
$204.19 M
Shares Outstanding
24.55 M
Public Float
-

Profile

Address
Lochhamer Straße 11
Martinsried Bayern (Bavaria) 82152
Germany
Employees -
Website http://www.medigene.de
Updated 07/08/2019
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments.

Financials

View All
Created with Highcharts 5.0.14MediGene AGNet Income. Fiscal year is January-December. All values EUR Thousands.10 28210 2825 7575 75712 99912 9999 4929 49213 57313 57317 04917 04920132014201520162017201805k10k15k20k
Created with Highcharts 5.0.14MediGene AGSales/Revenue. Fiscal year is January-December. All values EUR Thousands.4 2094 2095 1955 1953 1013 1014 1014 1017 6767 6767 5767 57620132014201520162017201802k4k6k8k10k

Horst Domdey
Chairman-Supervisory Board
Gerd Zettlmeissl
Member-Supervisory Board